nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Differentiation Pathway—INS—type 2 diabetes mellitus	0.00297	0.0133	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IGF1—type 2 diabetes mellitus	0.00288	0.0128	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—type 2 diabetes mellitus	0.00278	0.0124	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—MTR—type 2 diabetes mellitus	0.00234	0.0105	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CCND2—type 2 diabetes mellitus	0.0021	0.00936	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—PSMD6—type 2 diabetes mellitus	0.00205	0.00913	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—type 2 diabetes mellitus	0.00188	0.00838	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.00176	0.00785	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.00174	0.00777	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—TGFB1—type 2 diabetes mellitus	0.00173	0.00769	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.00172	0.00769	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.0017	0.00759	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP3A4—type 2 diabetes mellitus	0.0017	0.00757	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.00151	0.00674	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—type 2 diabetes mellitus	0.0015	0.00671	CbGpPWpGaD
Carbimazole—Headache—Linagliptin—type 2 diabetes mellitus	0.00146	0.00188	CcSEcCtD
Carbimazole—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00145	0.00187	CcSEcCtD
Carbimazole—Infection—Sitagliptin—type 2 diabetes mellitus	0.00144	0.00186	CcSEcCtD
Carbimazole—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00143	0.00184	CcSEcCtD
Carbimazole—Rash—Acarbose—type 2 diabetes mellitus	0.00143	0.00184	CcSEcCtD
Carbimazole—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00142	0.00184	CcSEcCtD
Carbimazole—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00142	0.00184	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.00142	0.00635	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.00142	0.00183	CcSEcCtD
Carbimazole—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00142	0.00183	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.00141	0.0063	CbGpPWpGaD
Carbimazole—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00141	0.00182	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.00141	0.00628	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.00141	0.00627	CbGpPWpGaD
Carbimazole—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.0014	0.00181	CcSEcCtD
Carbimazole—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.0014	0.00181	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.0014	0.00624	CbGpPWpGaD
Carbimazole—Nausea—Tolazamide—type 2 diabetes mellitus	0.0014	0.0018	CcSEcCtD
Carbimazole—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.0014	0.0018	CcSEcCtD
Carbimazole—Eosinophilia—Losartan—type 2 diabetes mellitus	0.0014	0.0018	CcSEcCtD
Carbimazole—Hepatitis—Valsartan—type 2 diabetes mellitus	0.0014	0.0018	CcSEcCtD
Carbimazole—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.0014	0.0018	CcSEcCtD
Carbimazole—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00139	0.00179	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.00139	0.0062	CbGpPWpGaD
Carbimazole—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.00139	0.00179	CcSEcCtD
Carbimazole—Hepatitis—Orlistat—type 2 diabetes mellitus	0.00138	0.00178	CcSEcCtD
Carbimazole—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.00138	0.00178	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—type 2 diabetes mellitus	0.00138	0.00614	CbGpPWpGaD
Carbimazole—Rash—Nateglinide—type 2 diabetes mellitus	0.00137	0.00177	CcSEcCtD
Carbimazole—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00137	0.00177	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.00137	0.00612	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00136	0.00176	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00176	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.00135	0.00604	CbGpPWpGaD
Carbimazole—Angioedema—Glyburide—type 2 diabetes mellitus	0.00135	0.00173	CcSEcCtD
Carbimazole—Nausea—Acarbose—type 2 diabetes mellitus	0.00134	0.00173	CcSEcCtD
Carbimazole—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00134	0.00172	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00132	0.00171	CcSEcCtD
Carbimazole—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00132	0.0017	CcSEcCtD
Carbimazole—Infection—Bromocriptine—type 2 diabetes mellitus	0.00131	0.00168	CcSEcCtD
Carbimazole—Jaundice—Irbesartan—type 2 diabetes mellitus	0.0013	0.00168	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—IL6—type 2 diabetes mellitus	0.0013	0.0058	CbGpPWpGaD
Carbimazole—Nausea—Nateglinide—type 2 diabetes mellitus	0.00129	0.00167	CcSEcCtD
Carbimazole—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.00129	0.00166	CcSEcCtD
Carbimazole—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00129	0.00166	CcSEcCtD
Carbimazole—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00129	0.00166	CcSEcCtD
Carbimazole—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00128	0.00165	CcSEcCtD
Carbimazole—Hepatitis—Metformin—type 2 diabetes mellitus	0.00127	0.00164	CcSEcCtD
Carbimazole—Angiopathy—Valsartan—type 2 diabetes mellitus	0.00127	0.00163	CcSEcCtD
Carbimazole—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00126	0.00163	CcSEcCtD
Carbimazole—Arthralgia—Glyburide—type 2 diabetes mellitus	0.00125	0.00162	CcSEcCtD
Carbimazole—Myalgia—Glyburide—type 2 diabetes mellitus	0.00125	0.00162	CcSEcCtD
Carbimazole—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.00125	0.00161	CcSEcCtD
Carbimazole—Urticaria—Glipizide—type 2 diabetes mellitus	0.00124	0.0016	CcSEcCtD
Carbimazole—Alopecia—Valsartan—type 2 diabetes mellitus	0.00123	0.00159	CcSEcCtD
Carbimazole—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00123	0.00159	CcSEcCtD
Carbimazole—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00123	0.00158	CcSEcCtD
Carbimazole—Jaundice—Losartan—type 2 diabetes mellitus	0.00123	0.00158	CcSEcCtD
Carbimazole—Alopecia—Orlistat—type 2 diabetes mellitus	0.00122	0.00157	CcSEcCtD
Carbimazole—Angioedema—Gliclazide—type 2 diabetes mellitus	0.00121	0.00156	CcSEcCtD
Carbimazole—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.0012	0.00155	CcSEcCtD
Carbimazole—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.0012	0.00155	CcSEcCtD
Carbimazole—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.0012	0.00154	CcSEcCtD
Carbimazole—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.0012	0.00154	CcSEcCtD
Carbimazole—Malaise—Gliclazide—type 2 diabetes mellitus	0.00119	0.00154	CcSEcCtD
Carbimazole—Rash—Repaglinide—type 2 diabetes mellitus	0.00119	0.00153	CcSEcCtD
Carbimazole—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00119	0.00153	CcSEcCtD
Carbimazole—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00119	0.00153	CcSEcCtD
Carbimazole—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00118	0.00153	CcSEcCtD
Carbimazole—Headache—Repaglinide—type 2 diabetes mellitus	0.00118	0.00152	CcSEcCtD
Carbimazole—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00118	0.00152	CcSEcCtD
Carbimazole—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00118	0.00152	CcSEcCtD
Carbimazole—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.00117	0.00151	CcSEcCtD
Carbimazole—TPO—Metabolism—BHMT—type 2 diabetes mellitus	0.00116	0.00519	CbGpPWpGaD
Carbimazole—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00116	0.00149	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.00115	0.00515	CbGpPWpGaD
Carbimazole—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00115	0.00149	CcSEcCtD
Carbimazole—Angiopathy—Metformin—type 2 diabetes mellitus	0.00115	0.00149	CcSEcCtD
Carbimazole—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00115	0.00148	CcSEcCtD
Carbimazole—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.00115	0.00148	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.00114	0.00509	CbGpPWpGaD
Carbimazole—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00113	0.00146	CcSEcCtD
Carbimazole—Hepatitis—Losartan—type 2 diabetes mellitus	0.00113	0.00145	CcSEcCtD
Carbimazole—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.00113	0.00145	CcSEcCtD
Carbimazole—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00113	0.00145	CcSEcCtD
Carbimazole—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00112	0.00145	CcSEcCtD
Carbimazole—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00112	0.00145	CcSEcCtD
Carbimazole—Nausea—Repaglinide—type 2 diabetes mellitus	0.00112	0.00144	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00112	0.00144	CcSEcCtD
Carbimazole—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00112	0.00144	CcSEcCtD
Carbimazole—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00111	0.00144	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.00111	0.00496	CbGpPWpGaD
Carbimazole—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00111	0.00143	CcSEcCtD
Carbimazole—Angioedema—Valsartan—type 2 diabetes mellitus	0.00111	0.00143	CcSEcCtD
Carbimazole—Pruritus—Glipizide—type 2 diabetes mellitus	0.0011	0.00142	CcSEcCtD
Carbimazole—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0011	0.00142	CcSEcCtD
Carbimazole—Angioedema—Orlistat—type 2 diabetes mellitus	0.0011	0.00141	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00109	0.00141	CcSEcCtD
Carbimazole—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00109	0.0014	CcSEcCtD
Carbimazole—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00108	0.0014	CcSEcCtD
Carbimazole—Malaise—Orlistat—type 2 diabetes mellitus	0.00108	0.0014	CcSEcCtD
Carbimazole—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00107	0.00138	CcSEcCtD
Carbimazole—Infection—Gliclazide—type 2 diabetes mellitus	0.00107	0.00138	CcSEcCtD
Carbimazole—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00107	0.00138	CcSEcCtD
Carbimazole—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00106	0.00137	CcSEcCtD
Carbimazole—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00106	0.00136	CcSEcCtD
Carbimazole—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00106	0.00136	CcSEcCtD
Carbimazole—Stomatitis—Ramipril—type 2 diabetes mellitus	0.00105	0.00135	CcSEcCtD
Carbimazole—Jaundice—Ramipril—type 2 diabetes mellitus	0.00105	0.00135	CcSEcCtD
Carbimazole—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00105	0.00135	CcSEcCtD
Carbimazole—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00104	0.00135	CcSEcCtD
Carbimazole—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00104	0.00134	CcSEcCtD
Carbimazole—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00103	0.00133	CcSEcCtD
Carbimazole—Myalgia—Valsartan—type 2 diabetes mellitus	0.00103	0.00133	CcSEcCtD
Carbimazole—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00103	0.00133	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00103	0.00132	CcSEcCtD
Carbimazole—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00103	0.00132	CcSEcCtD
Carbimazole—Angiopathy—Losartan—type 2 diabetes mellitus	0.00102	0.00132	CcSEcCtD
Carbimazole—Myalgia—Orlistat—type 2 diabetes mellitus	0.00102	0.00132	CcSEcCtD
Carbimazole—TPO—Metabolism—AANAT—type 2 diabetes mellitus	0.00102	0.00453	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGDS—type 2 diabetes mellitus	0.00102	0.00453	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00101	0.00131	CcSEcCtD
Carbimazole—Discomfort—Orlistat—type 2 diabetes mellitus	0.00101	0.0013	CcSEcCtD
Carbimazole—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00101	0.0013	CcSEcCtD
Carbimazole—Malaise—Metformin—type 2 diabetes mellitus	0.000997	0.00129	CcSEcCtD
Carbimazole—Alopecia—Losartan—type 2 diabetes mellitus	0.000997	0.00129	CcSEcCtD
Carbimazole—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00099	0.00128	CcSEcCtD
Carbimazole—Infection—Valsartan—type 2 diabetes mellitus	0.000985	0.00127	CcSEcCtD
Carbimazole—Rash—Glipizide—type 2 diabetes mellitus	0.000984	0.00127	CcSEcCtD
Carbimazole—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000983	0.00127	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000983	0.00127	CcSEcCtD
Carbimazole—Headache—Glipizide—type 2 diabetes mellitus	0.000978	0.00126	CcSEcCtD
Carbimazole—Infection—Orlistat—type 2 diabetes mellitus	0.000973	0.00125	CcSEcCtD
Carbimazole—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000972	0.00125	CcSEcCtD
Carbimazole—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000971	0.00125	CcSEcCtD
Carbimazole—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000968	0.00125	CcSEcCtD
Carbimazole—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000968	0.00125	CcSEcCtD
Carbimazole—TPO—Metabolism—CDO1—type 2 diabetes mellitus	0.000963	0.0043	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPD2—type 2 diabetes mellitus	0.000963	0.0043	CbGpPWpGaD
Carbimazole—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000963	0.00124	CcSEcCtD
Carbimazole—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000961	0.00124	CcSEcCtD
Carbimazole—Urticaria—Glyburide—type 2 diabetes mellitus	0.000955	0.00123	CcSEcCtD
Carbimazole—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000954	0.00123	CcSEcCtD
Carbimazole—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000951	0.00123	CcSEcCtD
Carbimazole—Myalgia—Metformin—type 2 diabetes mellitus	0.000942	0.00121	CcSEcCtD
Carbimazole—Malaise—Irbesartan—type 2 diabetes mellitus	0.000941	0.00121	CcSEcCtD
Carbimazole—Headache—Pioglitazone—type 2 diabetes mellitus	0.000937	0.00121	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000935	0.00121	CcSEcCtD
Carbimazole—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000934	0.0012	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—SRC—type 2 diabetes mellitus	0.000932	0.00416	CbGpPWpGaD
Carbimazole—Discomfort—Metformin—type 2 diabetes mellitus	0.00093	0.0012	CcSEcCtD
Carbimazole—Nausea—Glipizide—type 2 diabetes mellitus	0.000927	0.0012	CcSEcCtD
Carbimazole—TPO—Metabolism—AK1—type 2 diabetes mellitus	0.000919	0.0041	CbGpPWpGaD
Carbimazole—Rash—Glimepiride—type 2 diabetes mellitus	0.000919	0.00118	CcSEcCtD
Carbimazole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000918	0.00118	CcSEcCtD
Carbimazole—Rash—Sitagliptin—type 2 diabetes mellitus	0.000916	0.00118	CcSEcCtD
Carbimazole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000915	0.00118	CcSEcCtD
Carbimazole—Headache—Glimepiride—type 2 diabetes mellitus	0.000913	0.00118	CcSEcCtD
Carbimazole—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000911	0.00117	CcSEcCtD
Carbimazole—Headache—Sitagliptin—type 2 diabetes mellitus	0.00091	0.00117	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000903	0.00116	CcSEcCtD
Carbimazole—Angioedema—Losartan—type 2 diabetes mellitus	0.000898	0.00116	CcSEcCtD
Carbimazole—Infection—Metformin—type 2 diabetes mellitus	0.000897	0.00116	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000892	0.00115	CcSEcCtD
Carbimazole—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000889	0.00115	CcSEcCtD
Carbimazole—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000889	0.00115	CcSEcCtD
Carbimazole—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000889	0.00115	CcSEcCtD
Carbimazole—Malaise—Losartan—type 2 diabetes mellitus	0.000886	0.00114	CcSEcCtD
Carbimazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000885	0.00114	CcSEcCtD
Carbimazole—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000885	0.00114	CcSEcCtD
Carbimazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000884	0.00114	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000883	0.00114	CcSEcCtD
Carbimazole—Leukopenia—Losartan—type 2 diabetes mellitus	0.000879	0.00113	CcSEcCtD
Carbimazole—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000878	0.00113	CcSEcCtD
Carbimazole—Skin disorder—Metformin—type 2 diabetes mellitus	0.000877	0.00113	CcSEcCtD
Carbimazole—Nausea—Glimepiride—type 2 diabetes mellitus	0.000865	0.00112	CcSEcCtD
Carbimazole—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000863	0.00111	CcSEcCtD
Carbimazole—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000857	0.0011	CcSEcCtD
Carbimazole—Alopecia—Ramipril—type 2 diabetes mellitus	0.000855	0.0011	CcSEcCtD
Carbimazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000853	0.0011	CcSEcCtD
Carbimazole—Pruritus—Glyburide—type 2 diabetes mellitus	0.00085	0.0011	CcSEcCtD
Carbimazole—TPO—Metabolism—MAT1A—type 2 diabetes mellitus	0.000848	0.00378	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000848	0.00378	CbGpPWpGaD
Carbimazole—Infection—Irbesartan—type 2 diabetes mellitus	0.000846	0.00109	CcSEcCtD
Carbimazole—Myalgia—Losartan—type 2 diabetes mellitus	0.000836	0.00108	CcSEcCtD
Carbimazole—Arthralgia—Losartan—type 2 diabetes mellitus	0.000836	0.00108	CcSEcCtD
Carbimazole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000835	0.00108	CcSEcCtD
Carbimazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000834	0.00108	CcSEcCtD
Carbimazole—Rash—Bromocriptine—type 2 diabetes mellitus	0.000829	0.00107	CcSEcCtD
Carbimazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000828	0.00107	CcSEcCtD
Carbimazole—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000827	0.00107	CcSEcCtD
Carbimazole—Discomfort—Losartan—type 2 diabetes mellitus	0.000826	0.00107	CcSEcCtD
Carbimazole—Headache—Bromocriptine—type 2 diabetes mellitus	0.000823	0.00106	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000822	0.00106	CcSEcCtD
Carbimazole—TPO—Metabolism—HBA2—type 2 diabetes mellitus	0.000819	0.00365	CbGpPWpGaD
Carbimazole—TPO—Metabolism—G6PC—type 2 diabetes mellitus	0.000819	0.00365	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ENPP1—type 2 diabetes mellitus	0.000819	0.00365	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000819	0.00365	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ND1—type 2 diabetes mellitus	0.000819	0.00365	CbGpPWpGaD
Carbimazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000807	0.00104	CcSEcCtD
Carbimazole—Infection—Losartan—type 2 diabetes mellitus	0.000796	0.00103	CcSEcCtD
Carbimazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000795	0.00102	CcSEcCtD
Carbimazole—TPO—Metabolism—GCGR—type 2 diabetes mellitus	0.000793	0.00354	CbGpPWpGaD
Carbimazole—Urticaria—Valsartan—type 2 diabetes mellitus	0.000787	0.00102	CcSEcCtD
Carbimazole—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000786	0.00101	CcSEcCtD
Carbimazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000785	0.00101	CcSEcCtD
Carbimazole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000782	0.00101	CcSEcCtD
Carbimazole—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000781	0.00101	CcSEcCtD
Carbimazole—Urticaria—Orlistat—type 2 diabetes mellitus	0.000778	0.001	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000776	0.001	CcSEcCtD
Carbimazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000774	0.000998	CcSEcCtD
Carbimazole—Angioedema—Ramipril—type 2 diabetes mellitus	0.00077	0.000992	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—MTR—type 2 diabetes mellitus	0.000767	0.00342	CbGpPWpGaD
Carbimazole—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000763	0.000984	CcSEcCtD
Carbimazole—Malaise—Ramipril—type 2 diabetes mellitus	0.00076	0.000979	CcSEcCtD
Carbimazole—Rash—Glyburide—type 2 diabetes mellitus	0.000758	0.000977	CcSEcCtD
Carbimazole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000757	0.000976	CcSEcCtD
Carbimazole—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000754	0.000972	CcSEcCtD
Carbimazole—Headache—Glyburide—type 2 diabetes mellitus	0.000753	0.00097	CcSEcCtD
Carbimazole—TPO—Metabolism—CYTB—type 2 diabetes mellitus	0.000749	0.00334	CbGpPWpGaD
Carbimazole—TPO—Metabolism—OXCT1—type 2 diabetes mellitus	0.000749	0.00334	CbGpPWpGaD
Carbimazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000744	0.000959	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000743	0.00331	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.000733	0.00327	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00073	0.000942	CcSEcCtD
Carbimazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00073	0.000941	CcSEcCtD
Carbimazole—TPO—Metabolism—SRD5A1—type 2 diabetes mellitus	0.00073	0.00326	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000724	0.00323	CbGpPWpGaD
Carbimazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000722	0.00093	CcSEcCtD
Carbimazole—Urticaria—Metformin—type 2 diabetes mellitus	0.000717	0.000924	CcSEcCtD
Carbimazole—Myalgia—Ramipril—type 2 diabetes mellitus	0.000717	0.000924	CcSEcCtD
Carbimazole—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000717	0.000924	CcSEcCtD
Carbimazole—Nausea—Glyburide—type 2 diabetes mellitus	0.000714	0.00092	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000712	0.000918	CcSEcCtD
Carbimazole—Discomfort—Ramipril—type 2 diabetes mellitus	0.000708	0.000913	CcSEcCtD
Carbimazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000702	0.000905	CcSEcCtD
Carbimazole—Pruritus—Valsartan—type 2 diabetes mellitus	0.000701	0.000904	CcSEcCtD
Carbimazole—TPO—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000697	0.00311	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ACACA—type 2 diabetes mellitus	0.000697	0.00311	CbGpPWpGaD
Carbimazole—TPO—Metabolism—STAR—type 2 diabetes mellitus	0.000697	0.00311	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000696	0.0031	CbGpPWpGaD
Carbimazole—Pruritus—Orlistat—type 2 diabetes mellitus	0.000693	0.000893	CcSEcCtD
Carbimazole—Rash—Gliclazide—type 2 diabetes mellitus	0.00068	0.000877	CcSEcCtD
Carbimazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00068	0.000876	CcSEcCtD
Carbimazole—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000677	0.000872	CcSEcCtD
Carbimazole—Headache—Gliclazide—type 2 diabetes mellitus	0.000676	0.000871	CcSEcCtD
Carbimazole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000674	0.000869	CcSEcCtD
Carbimazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000673	0.000868	CcSEcCtD
Carbimazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000673	0.000868	CcSEcCtD
Carbimazole—TPO—Metabolism—ABCC8—type 2 diabetes mellitus	0.000668	0.00298	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CBS—type 2 diabetes mellitus	0.000668	0.00298	CbGpPWpGaD
Carbimazole—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000668	0.000861	CcSEcCtD
Carbimazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000661	0.000852	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000659	0.00294	CbGpPWpGaD
Carbimazole—TPO—Metabolism—COX2—type 2 diabetes mellitus	0.000643	0.00287	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000643	0.00287	CbGpPWpGaD
Carbimazole—Nausea—Gliclazide—type 2 diabetes mellitus	0.000641	0.000826	CcSEcCtD
Carbimazole—Pruritus—Metformin—type 2 diabetes mellitus	0.000639	0.000823	CcSEcCtD
Carbimazole—Urticaria—Losartan—type 2 diabetes mellitus	0.000637	0.000821	CcSEcCtD
Carbimazole—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000634	0.000817	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOA6—type 2 diabetes mellitus	0.000632	0.00282	CbGpPWpGaD
Carbimazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000628	0.000809	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000626	0.000807	CcSEcCtD
Carbimazole—Rash—Valsartan—type 2 diabetes mellitus	0.000625	0.000806	CcSEcCtD
Carbimazole—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000624	0.000805	CcSEcCtD
Carbimazole—Headache—Valsartan—type 2 diabetes mellitus	0.000621	0.0008	CcSEcCtD
Carbimazole—TPO—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000621	0.00277	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UCP2—type 2 diabetes mellitus	0.000621	0.00277	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UCP3—type 2 diabetes mellitus	0.000621	0.00277	CbGpPWpGaD
Carbimazole—Rash—Orlistat—type 2 diabetes mellitus	0.000618	0.000796	CcSEcCtD
Carbimazole—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000617	0.000795	CcSEcCtD
Carbimazole—Headache—Orlistat—type 2 diabetes mellitus	0.000614	0.000791	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000613	0.00273	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000606	0.0027	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.000605	0.0027	CbGpPWpGaD
Carbimazole—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000603	0.000777	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000598	0.00267	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000591	0.00264	CbGpPWpGaD
Carbimazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000591	0.000761	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AR—type 2 diabetes mellitus	0.00059	0.00263	CbGpPWpGaD
Carbimazole—Nausea—Valsartan—type 2 diabetes mellitus	0.000589	0.000759	CcSEcCtD
Carbimazole—TPO—Metabolism—PCK1—type 2 diabetes mellitus	0.000584	0.0026	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.000583	0.0026	CbGpPWpGaD
Carbimazole—Nausea—Orlistat—type 2 diabetes mellitus	0.000582	0.00075	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—type 2 diabetes mellitus	0.000579	0.00258	CbGpPWpGaD
Carbimazole—Rash—Metformin—type 2 diabetes mellitus	0.000569	0.000734	CcSEcCtD
Carbimazole—Dermatitis—Metformin—type 2 diabetes mellitus	0.000569	0.000733	CcSEcCtD
Carbimazole—Pruritus—Losartan—type 2 diabetes mellitus	0.000567	0.000731	CcSEcCtD
Carbimazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000566	0.00073	CcSEcCtD
Carbimazole—Headache—Metformin—type 2 diabetes mellitus	0.000566	0.000729	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.000561	0.0025	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HK1—type 2 diabetes mellitus	0.000547	0.00244	CbGpPWpGaD
Carbimazole—Urticaria—Ramipril—type 2 diabetes mellitus	0.000546	0.000704	CcSEcCtD
Carbimazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000543	0.000701	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000538	0.0024	CbGpPWpGaD
Carbimazole—Rash—Irbesartan—type 2 diabetes mellitus	0.000537	0.000692	CcSEcCtD
Carbimazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000537	0.000692	CcSEcCtD
Carbimazole—Nausea—Metformin—type 2 diabetes mellitus	0.000536	0.000691	CcSEcCtD
Carbimazole—Headache—Irbesartan—type 2 diabetes mellitus	0.000534	0.000688	CcSEcCtD
Carbimazole—TPO—Metabolism—GCKR—type 2 diabetes mellitus	0.000528	0.00235	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LPA—type 2 diabetes mellitus	0.000528	0.00235	CbGpPWpGaD
Carbimazole—TPO—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000528	0.00235	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000528	0.00235	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000513	0.00229	CbGpPWpGaD
Carbimazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000506	0.000653	CcSEcCtD
Carbimazole—TPO—Metabolism—ALDOB—type 2 diabetes mellitus	0.000506	0.00226	CbGpPWpGaD
Carbimazole—Nausea—Irbesartan—type 2 diabetes mellitus	0.000506	0.000652	CcSEcCtD
Carbimazole—Rash—Losartan—type 2 diabetes mellitus	0.000505	0.000652	CcSEcCtD
Carbimazole—Dermatitis—Losartan—type 2 diabetes mellitus	0.000505	0.000651	CcSEcCtD
Carbimazole—Headache—Losartan—type 2 diabetes mellitus	0.000502	0.000647	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.0005	0.00223	CbGpPWpGaD
Carbimazole—Pruritus—Ramipril—type 2 diabetes mellitus	0.000486	0.000627	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.000477	0.00213	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.000477	0.00213	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.000477	0.00213	CbGpPWpGaD
Carbimazole—Nausea—Losartan—type 2 diabetes mellitus	0.000476	0.000614	CcSEcCtD
Carbimazole—TPO—Metabolism—GLP1R—type 2 diabetes mellitus	0.000471	0.0021	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000465	0.00207	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000458	0.00204	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000439	0.00196	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000438	0.00196	CbGpPWpGaD
Carbimazole—Rash—Ramipril—type 2 diabetes mellitus	0.000433	0.000559	CcSEcCtD
Carbimazole—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000433	0.000558	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.000432	0.00193	CbGpPWpGaD
Carbimazole—Headache—Ramipril—type 2 diabetes mellitus	0.000431	0.000555	CcSEcCtD
Carbimazole—TPO—Metabolism—CPT1A—type 2 diabetes mellitus	0.00043	0.00192	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTR—type 2 diabetes mellitus	0.00043	0.00192	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.000425	0.00189	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NAMPT—type 2 diabetes mellitus	0.000422	0.00188	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LIPC—type 2 diabetes mellitus	0.000419	0.00187	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HBA1—type 2 diabetes mellitus	0.000419	0.00187	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GCK—type 2 diabetes mellitus	0.000419	0.00187	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000417	0.00186	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000409	0.00183	CbGpPWpGaD
Carbimazole—Nausea—Ramipril—type 2 diabetes mellitus	0.000408	0.000526	CcSEcCtD
Carbimazole—TPO—Metabolism—CETP—type 2 diabetes mellitus	0.000405	0.0018	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	0.000378	0.00169	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PSMD6—type 2 diabetes mellitus	0.000376	0.00168	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SNAP25—type 2 diabetes mellitus	0.000376	0.00168	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SREBF1—type 2 diabetes mellitus	0.000376	0.00168	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CTGF—type 2 diabetes mellitus	0.000369	0.00165	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMGCR—type 2 diabetes mellitus	0.000366	0.00163	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	0.000361	0.00161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.000361	0.00161	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000358	0.0016	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000357	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BHMT—type 2 diabetes mellitus	0.000354	0.00158	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000344	0.00153	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC2A1—type 2 diabetes mellitus	0.00034	0.00152	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A2—type 2 diabetes mellitus	0.00034	0.00152	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000332	0.00148	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GCG—type 2 diabetes mellitus	0.000326	0.00145	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000326	0.00145	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AANAT—type 2 diabetes mellitus	0.00031	0.00138	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGDS—type 2 diabetes mellitus	0.00031	0.00138	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000306	0.00136	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000295	0.00131	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPD2—type 2 diabetes mellitus	0.000294	0.00131	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CDO1—type 2 diabetes mellitus	0.000294	0.00131	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000287	0.00128	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000285	0.00127	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GNB3—type 2 diabetes mellitus	0.000281	0.00125	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000281	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AK1—type 2 diabetes mellitus	0.00028	0.00125	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMOX1—type 2 diabetes mellitus	0.00028	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000277	0.00123	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAT—type 2 diabetes mellitus	0.000276	0.00123	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	0.00027	0.0012	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOB—type 2 diabetes mellitus	0.000268	0.0012	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—type 2 diabetes mellitus	0.000261	0.00116	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000259	0.00115	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000259	0.00115	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000257	0.00115	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LPL—type 2 diabetes mellitus	0.000256	0.00114	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000253	0.00113	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000252	0.00113	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADCY5—type 2 diabetes mellitus	0.000251	0.00112	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.00025	0.00112	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HBA2—type 2 diabetes mellitus	0.00025	0.00111	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.00025	0.00111	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ND1—type 2 diabetes mellitus	0.00025	0.00111	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPX1—type 2 diabetes mellitus	0.00025	0.00111	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ENPP1—type 2 diabetes mellitus	0.00025	0.00111	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—G6PC—type 2 diabetes mellitus	0.00025	0.00111	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CD36—type 2 diabetes mellitus	0.000243	0.00108	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GCGR—type 2 diabetes mellitus	0.000242	0.00108	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPP2CA—type 2 diabetes mellitus	0.00024	0.00107	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000233	0.00104	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTHFR—type 2 diabetes mellitus	0.00023	0.00103	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000229	0.00102	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—OXCT1—type 2 diabetes mellitus	0.000228	0.00102	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	0.000228	0.00102	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARA—type 2 diabetes mellitus	0.000226	0.00101	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000223	0.000992	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AGT—type 2 diabetes mellitus	0.000219	0.000976	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CALM1—type 2 diabetes mellitus	0.000215	0.00096	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOE—type 2 diabetes mellitus	0.000215	0.000957	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	0.000212	0.000947	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000212	0.000947	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	0.000212	0.000947	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOA1—type 2 diabetes mellitus	0.000212	0.000946	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000206	0.000919	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	0.000204	0.000908	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	0.000204	0.000908	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000196	0.000874	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	0.000196	0.000874	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	0.000192	0.000858	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000192	0.000858	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	0.000189	0.000844	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000189	0.000844	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	0.000189	0.000844	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARG—type 2 diabetes mellitus	0.000187	0.000833	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000183	0.000818	CbGpPWpGaD
Carbimazole—TPO—Metabolism—INS—type 2 diabetes mellitus	0.000183	0.000817	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	0.000178	0.000793	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000175	0.000781	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000171	0.000762	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—type 2 diabetes mellitus	0.000168	0.000749	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	0.000167	0.000743	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000166	0.000742	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	0.000161	0.000717	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000161	0.000717	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	0.000161	0.000717	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000161	0.000717	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000161	0.000717	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NOS3—type 2 diabetes mellitus	0.000161	0.000717	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000155	0.00069	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	0.000154	0.000688	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.00015	0.000668	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—type 2 diabetes mellitus	0.000147	0.000655	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000147	0.000655	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000146	0.000652	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000145	0.000647	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	0.000143	0.00064	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000134	0.000597	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	0.000131	0.000585	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	0.000131	0.000585	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	0.000129	0.000574	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000128	0.00057	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	0.000128	0.00057	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	0.000128	0.00057	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	0.000128	0.00057	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000127	0.000566	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000125	0.000556	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	0.000123	0.00055	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000115	0.000513	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	0.000115	0.000511	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	0.000115	0.000511	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	0.000115	0.000511	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	0.000113	0.000502	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	0.000112	0.000497	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.00011	0.00049	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000109	0.000487	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000105	0.000468	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000104	0.000462	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000104	0.000462	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000101	0.000451	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000101	0.000449	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.94e-05	0.000443	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	9.94e-05	0.000443	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.57e-05	0.000382	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	8.57e-05	0.000382	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	8.53e-05	0.00038	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	8.41e-05	0.000375	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	8.17e-05	0.000364	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	7.95e-05	0.000354	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	7.8e-05	0.000348	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	7.64e-05	0.000341	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	7.61e-05	0.000339	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	7.41e-05	0.00033	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—type 2 diabetes mellitus	7.39e-05	0.000329	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.32e-05	0.000326	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	7.02e-05	0.000313	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	6.89e-05	0.000307	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	6.67e-05	0.000298	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	6.56e-05	0.000293	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	6.54e-05	0.000292	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	6.46e-05	0.000288	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	5.69e-05	0.000254	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	5.59e-05	0.000249	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	5.12e-05	0.000228	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.9e-05	0.000218	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	4.9e-05	0.000218	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	4.48e-05	0.0002	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	2.25e-05	0.0001	CbGpPWpGaD
